Delivery Order SPE2DB22D3501-SPE2DB24FUT65
Award Date 2/29/24
Potential Completion Date 3/21/24
Potential Value $6.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract has a ceiling value of $9,302.20 and a performance period through March 18, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems. This contract is part of a larger...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,651.10, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a medical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025. The contract is not set aside for any specific business type. In addition to this delivery order,...
- This is a $13,953.30 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The award is not associated with a set-aside program and has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a ceiling value of $4,651.10 and a completion date of July 23, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a medication, with a ceiling value of $13,953.30 and a performance period ending on May 21, 2025. This contract is not set aside and was awarded on a full and open competition basis. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The contract has a firm fixed price and a ceiling value of $13,953.30, with a performance period through May 30, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $2,197.41 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a prescription medication. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,976.65, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a specialty pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,953.30, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 27, 2025. This award is not associated with a set-aside designation. Amerisourcebergen...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a potential value of $2,197.41 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp, as a prime contractor, provides a wide range of pharmaceutical products and medical supplies to U.S. government...